ICCM Revenue and Competitors
Estimated Revenue & Valuation
- ICCM's estimated annual revenue is currently $22.9M per year.
- ICCM's estimated revenue per employee is $270,000
Employee Data
- ICCM has 85 Employees.
- ICCM grew their employee count by 5% last year.
ICCM's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Nursing | Reveal Email/Phone |
2 | Clinical Nurse Specialist | Reveal Email/Phone |
3 | Senior Recruitment Coordinator | Reveal Email/Phone |
4 | Clinical Nurse | Reveal Email/Phone |
ICCM Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 52 | 0% | N/A | N/A |
#2 | $37M | 137 | 5% | N/A | N/A |
#3 | $16.5M | 68 | -16% | N/A | N/A |
#4 | $42.5M | 143 | 4% | N/A | N/A |
#5 | $48.4M | 163 | 6% | N/A | N/A |
#6 | $25.1M | 93 | 0% | N/A | N/A |
#7 | $8.6M | 40 | 11% | N/A | N/A |
#8 | $234.2M | 694 | 5% | N/A | N/A |
#9 | $85.5M | 288 | 10% | N/A | N/A |
#10 | $24.8M | 92 | 7% | N/A | N/A |
What Is ICCM?
ICCM Ltd is a national specialist provider of complex care for adults and children with profound disabilities who choose to live in their own homes. We specialise in the fields of spinal cord injury, domiciliary ventilation, acquired brain injury and other neurological disorders.
keywords:N/AN/A
Total Funding
85
Number of Employees
$22.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ICCM News
Ra Medical Systems (NYSE:RMED) and IceCure Medical (NASDAQ:ICCM) Head to Head Analysis. Posted by admin on Apr 25th, 2022.
IceCure Medical (TLV:ICCM) shareholder returns have been solid, earning 241% in 5 years. By: Simply Wall St. Published: April 21, 2022. TASE:ICCM...
Financial Survey: IceCure Medical (NASDAQ:ICCM) vs. Westaim (OTCMKTS:WEDXF). Posted by admin on Apr 23rd, 2022. Share on Twitter Share on Facebook Share on...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.5M | 86 | -10% | N/A |
#2 | $15.1M | 87 | 9% | N/A |
#3 | $15M | 105 | -2% | N/A |
#4 | $15M | 120 | 3% | N/A |
#5 | $15M | 121 | 2% | N/A |